A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304) Meeting Abstract
| Authors: | Ingham, M.; Mahoney, M. R.; Remotti, F.; Shergill, A.; Dickson, M. A.; Riedel, R. F.; Attia, S.; Elias, A. D.; Liebner, D. A.; Agulnik, M.; Thornton, K. A.; Monga, V.; Van Tine, B. A.; Schwartz, G. K.; Tap, W. D. |
| Abstract Title: | A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 565s |
| Language: | English |
| ACCESSION: | WOS:000560368300422 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.11562 |
| Notes: | Meeting Abstract: 11562 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
